Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RotaTeq in HIV-1 infected and uninfected children
NCT00880698Phase 2Completed
- Sponsor
- National Institute of Allergy and Infectious Diseases
- Start
- Dec 2009
- Primary completion
- Jan 2014
- Modality
- Live Biotherapeutic Products, Vaccines & Immunotherapeutics
- Countries
- 4
01
Overview
A Phase 2 trial of rotavirus vaccine, live, oral, pentavalent in rotavirus infection, sponsored by National Institute of Allergy and Infectious Diseases. Started Dec 2009; status: completed.
02
Drugs
rotavirus vaccine, live, oral, pentavalent
03
Conditions
rotavirus infection
Beyond the preview
Go deeper on NCT00880698.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00880698.